ESCRS - Systematic Review Awards

Systematic Review Awards

Evidence-based medicine supports quality science

The 2022 ESCRS Systematic Review Award (“SRA”) is a new initiative sponsored by the ESCRS to produce a high quality body of research aimed to prepare, collate, analyse, synthesise and report medical research.  

The initiative will provide a new scholarly output in the field of cataract & refractive surgery or medicine focused on the methodology created by the Cochrane Library ( and / or  

As defined by the Cochrane Library*:  “A systematic review attempts to identify, appraise and synthesize all the empirical evidence that meets pre-specified eligibility criteria to answer a specific research question. Researchers conducting systematic reviews use explicit, systematic methods that are selected with a view aimed at minimizing bias, to produce more reliable findings to inform decision making.


Applicants are encouraged to refer online resources here, including a brief introduction on “Why systematic reviews matter”, 

The competition is open to all ophthalmologists (MD, and/or Ph.D., or experienced ophthalmic nurse) holding a full time clinical/research post at an EU-based clinical or academic centre. 

ESCRS will offer up to five (5) SRAs will be offered in 2022-23.

Each applicant needs to provide an original Proposal relevant to a focused research question in cataract or refractive medicine or surgery and the applicant may wish to register their proposal with PROSPERO ( and adherence with PRISMA (

Funding may be offered for a maximum of €10,000 for each SRA applicant

At the completion of the research, the systematic review manuscript must be submitted to an accredited journal, acceptable to the ESCRS. 

Finally, given that systematic reviews require specific expertise, it will be a condition for the applicant to either (a) submit a previous published systematic review in a professional medical journal or, (b) the applicant will request a Supervisor or Medical Librarian available in the applicant’s institute / hospital / university. 

If an applicant is not member of ESCRS, the SRA application shall require written support from an ESCRS Member with at least 3 years of membership of the Society.  The support of the ESCRS Member is mandatory.

The amount for funding that may be awarded to a successful applicant, for up to €10,000 (maximum), and for a project with a duration no longer than 1 year. 

How to apply

The competition is now open with three rolling deadlines of April 6th, July 27th and November 23rd, over 2022

Once applications are received, they will be sent directly to the Clinical Trials Research team.